Trial intelligence / Profile preview

Evening primrose oil vs misoprostol for cervical ripening before hysteroscopy

IRCT20220930056059N2Phase 3Completed

Sponsor
Tabriz University of Medical Sciences
Start
Dec 2022
Modality
Classical Binding Small Molecules → Small Molecules, Small Molecules
Countries
1
01

Overview

Phase 3, randomised trial in Fibromyoma (LM) comparing Evening primrose oil with Misoprostol (2 arms). Primary endpoint: Cervical ripening efficacy. Started Dec 2022; status: completed.

02

Drugs

evening primrose oilmisoprostol
03

Conditions

Fibromyoma (LM)

Beyond the preview

Go deeper on IRCT20220930056059N2.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT20220930056059N2.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call